Drugs / mesenchymal stem cells (umbilical cord)
mesenchymal stem cells (umbilical cord)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06518902 | Aug 2024 → Jul 2025 overdue | ischemic stroke | National Engineering Center of Cell Products | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesenchymal stem cells (umbilical cord) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06518902 ↗ |
| Modality | Cell therapy | “Umbilical Cord-derived Mesenchymal Stem Cell Infusion” NCT06518902 ↗ |